Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
European Journal of Pharmacology|July 27, 2010
Protease-activated receptor 1 antagonists prevent platelet aggregation and adhesion without affecting thrombin timeFlorence Nadal-Wollbold, Arnaud Bocquet, Thierry Bourbon, et al.FEBS Letters|November 19, 2002
Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-RafFlorence Nadal-Wollbold, Marc Pawlowski, Sylviane Lévy-Toledano, et al.Biochemical Pharmacology|March 2, 2010
Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the ratRobert Létienne, Anne Leparq-Panissié, Yannick Calmettes, et al.Biochimica Et Biophysica Acta. General Subjects|October 30, 2016
Proteomic and transcriptomic investigation of acne vulgaris microcystic and papular lesions: Insights in the understanding of its pathophysiologyJusal Quanico, Jean-Pascal Gimeno, Florence Nadal-Wollbold, et al.The Journal of Investigative Dermatology|March 5, 2015
Elastin Modification by 4-Hydroxynonenal in Hairless Mice Exposed to UV-A. Role in Photoaging and Actinic ElastosisPauline Larroque-Cardoso, Caroline Camaré, Florence Nadal-Wollbold, et al.Journal of Medicinal Chemistry|October 2, 2009
Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivoMichel Perez, Marie Lamothe, Catherine Maraval, et al.Pageof 1